Immucell Corp share price logo

Immucell Corp Share Price

NASDAQ: ICCC

Small Cap

$6.37

+0.02

(+0.31%)

as on

Immucell Corp Stock Performance

as on April 3, 2026 at 6:57 am IST

  • Day's Low

    Day's High

    $6.25
    $6.49
    downward going graph

    1.88%

    Downside

    1.88%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $4.52
    $7.60
    downward going graph

    29.04%

    Downside

    19.31%

    Upside

    downward going graph

Immucell Corp share price movements today

Previous Close
$6.35
Open
$6.36
Volume
110.7K
Day's Low - High
$6.25 - $6.49
52 Week Low - High
$4.52 - $7.60

Immucell Corp Historical Returns

1 Month Return
-0.31 %
3 Month Return
+ 8.78 %
1 Year Return
+ 20.15 %
3 Year Return
+ 28.8 %
5 Year Return
-34.95 %

Immucell Corp Stock Fundamentals & Key Indicators

Check Immucell Corp market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$54.7M

EPS (TTM)

0

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

-0.63%

PE Ratio (TTM)

28.81

Industry PE ratio

0

PEG Ratio

0

EBITDA

4.8M

Revenue (TTM)

28.3M

Profit Margin

6.23%

Return On Equity TTM

6.61%

Immucell Corp Stock Valuation

Track how Immucell Corp P/E has moved over time to understand its valuation trends.

Immucell Corp in the last 5 years

  • Overview

  • Trends

Lowest (-195.03x)

June 30, 2021

Industry (0.00x)

April 4, 2026

Today (28.81x)

April 4, 2026

Highest (71.91x)

March 31, 2022

LowHigh

Today’s Price to Earnings Ratio: 28.81x

Immucell Corp vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Immucell Corp with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
Immucell Corp image
Immucell Corp
BUY$54.7M-34.95%28.816.23%
Alnylam Pharmaceuticals, Inc. image
Alnylam Pharmaceuticals, Inc.
BUY$42.3B124.84%136.858.45%
Beone Medicines Ltd image
Beone Medicines Ltd
NA$35.7BNA125.835.37%
Vertex Pharmaceuticals Incorporated image
Vertex Pharmaceuticals Incorporated
BUY$111.4B105.93%28.6632.94%
Regeneron Pharmaceuticals, Inc. image
Regeneron Pharmaceuticals, Inc.
BUY$80.5B60.41%18.3831.41%

Stock Returns calculator for Immucell Corp Stock including INR - Dollar returns

The Immucell Corp stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Immucell Corp investment value today

Current value as on today

₹1,28,237

Returns

₹28,237

(+28.24%)

Returns from Immucell Corp Stock

₹18,843 (+18.84%)

Dollar Impact

₹9,394 (+9.39%)

Analyst Recommendation on Immucell Corp Stock

Based on 7 analysts

BUY

85.71%

Buy

14.29%

Hold

0.00%

Sell

Based on 7 analysts, 85.71% of analysts recommend a 'BUY' rating for Immucell Corp. Average target price of $14

Immucell Corp Share Price Target

Get share price movements and forecasts by analysts on Immucell Corp.

What analysts predicted

54.5%UPSIDE

Target Price

$14

Current Price

$6.37

Analyzed by

7 Analysts

Target

$14.00

Immucell Corp target price $14, a slight upside of 54.5% compared to current price of $6.37. According to 7 analysts rating.

Immucell Corp Stock’s Investor Sentiment and Interest

Search interest for Immucell Corp Stock has decreased by -81% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-81% versus previous 30 day period

Immucell Corp Quarterly Profit & Loss

All numbers in Millions USD

Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Total Revenue
5
5
7
5
6
7
8
6
5
7
Gross Profit
1
1
2
1
1
2
3
2
2
2
Operating Income
-1
-1
0
-1
0
0
1
0
0
0
EBITDA
0
0
0
0
0
1
1
1
0
0
Interest Expense
0
0
0
0
0
0
0
0
0
0
Depreciation
0
0
0
0
0
0
0
0
0
0
Income Before Tax
0
-1
0
-1
0
0
1
0
0
-2
Income Tax Expense
0
0
0
0
0
0
0
0
0
0
Net Income
0
-1
0
-1
0
0
1
0
0
-2
Net Profit Margin
-17.42%
-22.37%
-6.03%
-27.99%
-11.67%
6.64%
17.94%
7.79%
-2.54%
-37.36%

Immucell Corp Annual Profit & Loss

All numbers in Millions USD

Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
9
10
10
13
15
19
18
17
26
27
Gross Profit
5
5
5
6
6
8
7
4
7
11
Operating Income
0
0
-1
0
-1
0
-2
-5
-1
1
EBITDA
1
0
0
1
0
2
0
-2
1
4
Interest Expense
0
0
0
0
0
0
0
0
0
0
Depreciation
-
0
1
2
2
2
2
2
2
2
Income Before Tax
0
0
-1
-1
-1
0
-2
-5
-2
-1
Income Tax Expense
0
0
0
0
0
0
0
0
0
0
Net Income
0
0
-2
-1
-1
0
-2
-5
-2
-1
Net Profit Margin
5.33%
-1.61%
-21.14%
-9.44%
-6.66%
-0.41%
-13.43%
-33.05%
-8.14%
-3.76%

Immucell Corp Quarterly Cash Flow

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Net Income
-1
0
-1
0
0
1
0
0
-1
Operating Cash Flow
-
0
0
0
0
1
1
-1
-1
Investing Cash Flow
-
0
0
0
0
0
0
0
0
Financing Cash Flow
-
0
0
3
0
0
0
0
0
Change in Cash
-
0
0
2
0
0
1
-2
0

Immucell Corp Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
0
-2
-1
-1
0
-2
-5
-2
-1
Operating Cash Flow
1
0
0
1
0
-1
-4
0
2
Investing Cash Flow
-12
-1
-3
-2
-1
-3
-1
0
-1
Financing Cash Flow
9
0
6
1
3
1
1
2
-1
Change in Cash
-1
-1
3
0
3
-4
-4
2
0

Global Institutional Holdings in Immucell Corp

Funds
Holdings
Renaissance Technologies Corp
1.67%
Cresset Asset Management, LLC
1.5%
Citadel Advisors Llc
0.44%
BlackRock Inc
0.18%
Prosperity Planning, Inc.
0.18%
See all

Immucell Corp News & Key Events

    Insights on Immucell Corp

    Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

    • imgPOSITIVE IMPACT

      Revenue Rich

      img

      Revenue is up for the last 2 quarters, 5.50M → 7.62M (in $), with an average increase of 27.8% per quarter

    • imgNO EFFECT

      Against Peers

      img

      In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 35.3% return, outperforming this stock by 15.2%

    • imgNO EFFECT

      Against Peers

      img

      In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 58.8% return, outperforming this stock by 28.7%

    • imgNEGATIVE IMPACT

      Price Dip

      img

      In the last 7 days, ICCC stock has moved down by -1.2%

    • imgNEGATIVE IMPACT

      Profit Down

      img

      Netprofit is down for the last 4 quarters, 1.44M → -2.84M (in $), with an average decrease of 710.6% per quarter

    About Immucell Corp

    immucell corporation is a biotechnology company based out of portland maine. immucell's focus is to create scientifically-proven and practical products that result in a measurable economical impact on animal health and productivity in the dairy and beed industries.
    OrganisationImmucell Corp
    Headquarters56 Evergreen Drive, Portland, ME, United States, 04103
    IndustryHealth Technology
    CEOMr. P. F. Olivier Te Boekhorst
    E-voting on sharesClick here to vote

    Key Management of Immucell Corp

    Name

    Title

    Mr. A. Gustavo Scaffa

    Senior Director of Quality

    John W. Zinckgraf

    Director of Product Development

    Ms. Bobbi Jo Brockmann

    VP of Sales & Marketing and Director

    Mr. P. F. Olivier Te Boekhorst

    President, CEO & Director

    Mr. Timothy C. Fiori

    CFO, Secretary, Treasurer & Director

    Ms. Elizabeth S. Toothaker

    Director of Finance & Administration and Controller

    FAQs

    What is Immucell Corp share price today?

    Immucell Corp share price today is $6.37 as on at the close of the market. Immucell Corp share today touched a day high of $6.49 and a low of $6.25.

    What is the 52 week high and 52 week low for Immucell Corp share?

    Immucell Corp share touched a 52 week high of $7.6 on and a 52 week low of $4.52 on . Immucell Corp stock price today i.e. is closed at $6.37,which is 16.18% down from its 52 week high and 40.93% up from its 52 week low.

    What is Immucell Corp's market capitalisation today?

    Immucell Corp market capitalisation is $0.00T as on .

    How to invest in Immucell Corp Stock (ICCC) from India?

    1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
    2. Step 2: Search for Immucell Corp on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Immucell Corp Shares that will get you 0.2355 shares as per Immucell Corp share price of $6.37 per share as on April 3, 2026 at 1:27 am IST.

    What is the minimum amount required to buy Immucell Corp Stock (ICCC) from India?

    Indian investors can start investing in Immucell Corp (ICCC) shares with as little as ₹92.67 or $1 (as of ) using the INDmoney app.
    For example: If you want to invest $10 or ₹926.70 in Immucell Corp stock (as per the Rupee-Dollar exchange rate as on ). Based on Immucell Corp share’s latest price of $6.37 as on April 3, 2026 at 1:27 am IST, you will get 1.5699 shares of Immucell Corp. Learn more about fractional shares .

    What are the returns that Immucell Corp has given to Indian investors in the last 5 years?

    Immucell Corp stock has given -34.95% share price returns and 26.81% dollar appreciation to an Indian investor in the last 5 years.
    Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?